Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivekjyoti Banerjee

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Oncotarget|April 17, 2017
Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cellsAditi Banerjee, Vivekjyoti Banerjee, Steven Czinn, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 26, 2018
Upregulation of RASSF1A in Colon Cancer by Suppression of Angiogenesis Signaling and Akt ActivationThomas G Blanchard, Rena Lapidus, Vivekjyoti Banerjee, et al.
European Journal of Pharmacology|February 12, 2021
Synergistic potential of dual andrographolide and melatonin targeting of metastatic colon cancer cells: Using the Chou-Talalay combination index methodVivekjyoti Banerjee, Neha Sharda, Jared Huse, et al.
ACM Transactions on Applied Perception|August 12, 2024
Twin Identification over Viewpoint Change: A Deep Convolutional Neural Network Surpasses HumansConnor J Parde, Virginia E Strehle, Vivekjyoti Banerjee, et al.
Cancers|February 13, 2019
Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon CancerThomas G Blanchard, Steven J Czinn, Vivekjyoti Banerjee, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Oncotarget|April 17, 2017
Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cellsAditi Banerjee, Vivekjyoti Banerjee, Steven Czinn, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 26, 2018
Upregulation of RASSF1A in Colon Cancer by Suppression of Angiogenesis Signaling and Akt ActivationThomas G Blanchard, Rena Lapidus, Vivekjyoti Banerjee, et al.
European Journal of Pharmacology|February 12, 2021
Synergistic potential of dual andrographolide and melatonin targeting of metastatic colon cancer cells: Using the Chou-Talalay combination index methodVivekjyoti Banerjee, Neha Sharda, Jared Huse, et al.
ACM Transactions on Applied Perception|August 12, 2024
Twin Identification over Viewpoint Change: A Deep Convolutional Neural Network Surpasses HumansConnor J Parde, Virginia E Strehle, Vivekjyoti Banerjee, et al.
Cancers|February 13, 2019
Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon CancerThomas G Blanchard, Steven J Czinn, Vivekjyoti Banerjee, et al.
Pageof 1